ERYTHROMYCIN (ERYTHROMYCIN) — FDA Approval ANDA212015 (TORRENT)
ERYTHROMYCIN (ERYTHROMYCIN) — FDA Approval ANDA212015 (TORRENT) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ERYTHROMYCIN; Active ingredients: ERYTHROMYCIN; Application number: ANDA212015.
| Brand name | ERYTHROMYCIN |
|---|---|
| Active ingredients | ERYTHROMYCIN |
| Application number | ANDA212015 |
| Sponsor | TORRENT |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20200706 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →